(@sabaghassemi.bsky.social)

Our new paper in at ‪@natbiomedeng.nature.com‬: A “leukemia-on-a-chip” developed in collaboration with NYU lets us track CAR T cells in real time, seeing them act in a human-like system. Big thanks to everyone involved! ‪@pennmedresearch.bsky.social @pennmedicine.bsky.social

loading . . .

Bioengineered immunocompetent preclinical trial-on-chip tool enables screening of CAR T cell therapy for leukaemia - Nature Biomedical Engineering An ex vivo organotypic and immunocompetent human leukaemia chip system is used for CAR T cell therapy modelling and screening of patient response. https://www.nature.com/articles/s41551-025-01428-2